EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Cancer

ISSN 0008-543X · Wiley

Neueste Artikel

  1. Patient reimbursement in therapeutic cancer clinical trials: An 18‐year multicenter experience

    Sukh Makhnoon, Ang Gao, Jessica L. Lee, Puja Umaretiya, Caitlyn Miller, Song Zhang, Arthi Sridhar, Erin L. Williams, Dana L. Dornsife, Robert G. Johnson, Ashley Santaniello, Loren Bryant, Navid Sadeghi, Ryan D. Nipp, Beverly Moy, Hala T. Borno, Sylvia Zhang, Darcy V. Spicer, Patrick J. Leavey, Heather E. Kitzman, Lorna Haughton McNeill, Carmen E. Guerra, David E. Gerber

    Erschienen: 2026-11-15DOI: 10.1002/cncr.70625

  2. A multicenter, prospective, phase 2 trial on proton re‐irradiation for patients with previously treated head and neck cancer

    Edward Christopher Dee, Christopher A. Barker, Noah S. Kalman, Yingzhi Wu, Charlie White, Zhigang Zhang, Haibo Lin, Daphna Y. Gelblum, Yao Yu, Jung Julie Kang, C. Jillian Tsai, Kaveh Zakeri, Linda Chen, Sean M. McBride, Achraf Shamseddine, Loren S. Michel, Lara A. Dunn, Alan L. Ho, Marc A. Cohen, Ian Ganly, Jennifer R. Cracchiolo, Richard J. Wong, Paul B. Romesser, Nadeem Riaz, Eric J. Sherman, Nancy Y. Lee

    Erschienen: 2026-11-01DOI: 10.1002/cncr.70643

  3. Body mass index at diagnosis, postdiagnosis change, and role of metabolic comorbidities in relation to survival in nonmetastatic renal cell carcinoma patients

    Monica Sarker, Zhengyi Deng, Eric C. Kauffman, Li Tang, Marilyn L. Kwan, Marvin E. Langston, Sumati Gupta, G. Daniel Grass, Eric A. Singer, Yousef Zakharia, Paul V. Viscuse, Laura Graham, Saum Ghodoussipour, Bodour Salhia, Sean Q. Kern, Adanma Ayanambakkam, Zin Myint, Jennifer King, Seyi Oderinde, Michelle L. Churchman, Robert J. Rounbehler, Ken Batai

    Erschienen: 2026-11-01DOI: 10.1002/cncr.70653

  4. Reply to “Structured rehabilitation for terminal cancer: Aligning the evidence with the setting that funds it”

    Nanako Nishiyama, Yoshinobu Matsuda, Noriko Fujiwara, Keiichi Narita, Shunsuke Oyamada, Keisuke Ariyoshi, Yukiko Hosono, Kazuaki Kushi, Katsuaki Ichimaru, Ritsuko Yabuki, Keisuke Kaneishi, Kiriko Abe, Takahiro Fujihara, Yoshihito Kono, Kozue Suzuki, Tae Kinoshita, Takeshi Sasara, Masato Nakajima, Hironori Mawatari, Hiroki Sugawara, Kentaro Nobutani, Yuriko Shindoh, Koichiro Kobayashi, Takashi Yamaguchi, Ryuji Iwaki, Yosuke Kitazoe, Yoshiaki Kanai, Junya Ueno, Tesshin Fukumi, Ryouhei Ishii, Nobuhisa Nakajima

    Erschienen: 2026-11-01DOI: 10.1002/cncr.70659

  5. Eltrombopag during induction chemotherapy in older patients with newly diagnosed acute myeloid leukemia is safe and reduces platelet transfusion requirements: The EPAG‐2015 French Innovative Leukemia Organization phase 2 randomized trial

    Arnaud Pigneux, Pierre‐Yves Dumas, Marc Bernard, Norbert Vey, Audrey Bidet, Ariane Mineur, Aline Schmidt, Martin Carré, Mario Ojeda, Sarah Bertoli, Anne Banos, Pierre Peterlin, Romain Guièze, Yohan Desbrosses, Gabrielle Roth Guepin, Célestine Simand, Thibaut Leguay, Emmanuel Gyan, Eric Jourdan, Jean‐Philippe Vial, Tony Marchand, Yosr Hicheri, Marie C. Béné, Jean Francois Hamel, Christian Récher

    Erschienen: 2026-11-01DOI: 10.1002/cncr.70669

  6. Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower‐risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo‐controlled trial

    Stine Ulrik Mikkelsen, Ali Al‐Mousawi, Amalie Bach Puglisi, Anders Pommer Vallentin, Astrid Østergaard Mortensen, Zachary Madaj, Toshinori Hinoue, Heidi Naomi Ottesen, Jakob Schmidt Jespersen, Linn Gillberg, Morten Tulstrup, Niels Richard Hansen, Jakob Werner Hansen, Mette Klarskov Andersen, Stacey Lyn Thomas, Christine Isaguirre, Ryan Sheldon, Marie Adams, Ryan Burgos, Stephen Baylin, Bo Kok Mortensen, Casey Lee O’Connell, Marianne Tang Severinsen, Peter William Laird, Jens Lykkesfeldt, Peter Jones, Kirsten Grønbæk

    Erschienen: 2026-10-01DOI: 10.1002/cncr.70549

  7. Impact of post‐chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children’s Oncology Group AREN0532, AREN0533, and AREN03B2 studies

    Nicholas F. Evageliou, Lindsay A. Renfro, Kelly L. Vallance, Carly R. Varela, Daniel J. Benedetti, Nicholas G. Cost, Peter F. Ehrlich, John A. Kalapurakal, Geetika Khanna, Jennifer H. Aldrink, Richard D. Glick, Michael V. Ortiz, Lauren N. Parsons, Arnold C. Paulino, Maddy Artunduaga, Ethan A. Smith, David B. Dix, Conrad V. Fernandez, Jeffrey S. Dome, James I. Geller, Elizabeth A. Mullen

    Erschienen: 2026-10-01DOI: 10.1002/cncr.70610

  8. Outcomes of adult patients with Li‐Fraumeni syndrome and myeloid neoplasms

    Jayastu Senapati, Hiam M. Abdel‐Salam, Vladislav D. Jdanov, Sanam Loghavi, Ashley Woodson, Jessica Corredor, Gautam Borthakur, Naval G. Daver, Tapan M. Kadia, Koichi Takahashi, Yesid Alvarado, Naveen Pemmaraju, Uday R. Popat, Elizabeth J. Shpall, Farhad Ravandi, Florencia McAllister, Najat C. Daw, Guillermo Garcia‐Manero, Banu K. Arun, Courtney D. DiNardo

    Erschienen: 2026-10-01DOI: 10.1002/cncr.70613

  9. Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis

    Hira Mian, Muhammad Salman Faisal, Tiening Chen, Ruta Brazauskas, Temitope Oloyede, Nausheen Ahmed, Aimaz Afrough, Larry D. Anderson, Rahul Banerjee, Jesus Berdeja, Aram Bidikian, Jakob Devos, Binod Dhakal, Ajoy Dias, Danai Dima, Yvonne A. Efebera, Lohith Gowda, Doris K. Hansen, Hamza Hashmi, Heather J. Landau, Lazaros Lekakis, Abu‐Sayeef Mirza, Ravi Narra, Krina Patel, Ashley E. Rosko, Mark Schroeder, Surbhi Sidana, Saad Usmani, Marcelo C. Pasquini, Taiga Nishihori, Othman Salim Akhtar, Meera Mohan

    Erschienen: 2026-10-01DOI: 10.1002/cncr.70614

  10. External validation of the NADIR model for early prostate‐specific antigen response prediction in enzalutamide‐treated metastatic hormone‐sensitive prostate cancer: An analysis of the ARCHES trial

    Soumyajit Roy, Andrew J. Armstrong, Neeraj Agarwal, Rana R. McKay, Angela Y. Jia, Samuel Lichtman‐Mikol, Pedro C. Barata, Jorge A. Garcia, Jason R. Brown, Yashasvi Mumgandi, Spyridon P. Basourakos, Iris Y. Sheng, Amar U. Kishan, Nicholas G. Zaorsky, Jonathan E. Shoag, Scott C. Morgan, Christopher J. D. Wallis, Yilun Sun, Eric J. Small, Fred Saad, Neal D. Shore, Daniel E. Spratt

    Erschienen: 2026-10-01DOI: 10.1002/cncr.70615

Jahrgänge

2026 · 2972025 · 6312024 · 5352023 · 5092022 · 5922021 · 6552020 · 7052019 · 6282018 · 6502017 · 6932016 · 5802015 · 6892014 · 6332013 · 6792012 · 8272011 · 7592010 · 8232009 · 6982008 · 8502007 · 7702006 · 8692005 · 8182004 · 8112003 · 8622002 · 9192001 · 9432000 · 1.2681999 · 1.2881998 · 1.1941997 · 1.1631996 · 1.3621995 · 8481994 · 1.0171993 · 1.3091992 · 9881991 · 1.0321990 · 9731989 · 8881988 · 8801987 · 920

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.